Coexpression of CD 5 and CD 43 predicts worse prognosis in diffuse large B‐cell lymphoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Coexpression of CD 5 and CD 43 predicts worse prognosis in diffuse large B‐cell lymphoma

Published:2018-07-17 Issue:9 Volume:7 Page:4284-4295
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Med

Author:

Ma Xiao‐bo¹^ORCID,Zhong Yan‐ping¹,Zheng Yan¹,Jiang Jing²,Wang Yin‐ping¹

Affiliation:

1. Department of PathologyFirst Hospital of Jilin University Changchun China

2. Division of Clinical EpidemiologyFirst Hospital of Jilin University Changchun China

Funder

Foundation of Jilin Educational Committee

Youth Foundation of the First Hospital of Jilin University

Publisher

Wiley

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.1674

Reference59 articles.

1. Diffuse large B-cell lymphoma: a heterogeneous group of non-Hodgkin lymphomas comprising several distinct clinicopathological entities

2. CHOP Chemotherapy plus Rituximab Compared with CHOP Alone in Elderly Patients with Diffuse Large-B-Cell Lymphoma

3. Diffuse large B-cell lymphoma

4. A Predictive Model for Aggressive Non-Hodgkin's Lymphoma

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent advances in CD5+ diffuse large B-cell lymphoma;Annals of Hematology;2024-08-28

2. Comparison of the IHC Markers CD138 and CD43 in Oral Leukoplakia: An Original Research;Journal of Pharmacy and Bioallied Sciences;2023-07

3. Targeting CD43 optimizes cancer immunotherapy through reinvigorating antitumor immune response in colorectal cancer;Cellular Oncology;2023-03-15

4. Identifying aggressive subsets within diffuse large B-cell lymphoma: implications for treatment approach;Expert Review of Anticancer Therapy;2022-04-18

5. CD5+ diffuse large B-cell lymphoma: a narrative review;Leukemia & Lymphoma;2021-07-21

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3